Yi He Ling
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Peptidase Inhibition and Analysis
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 2
- Glycosylation and Glycoproteins Research 1
- Oncology 7
- Cancer-related Molecular Pathways 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Román Pérez-Soler (11 shared papers)Waldemar Priebe (3 shared papers)Adel K. El‐Naggar (1 shared paper)Leonard Liebes (2 shared papers)Jian Jiang (2 shared papers)Julian Adams (2 shared papers)Franco M. Muggia (2 shared papers)Peter J. Elliott (2 shared papers)
- Journals
- International Journal of Oncology (1 paper)European Journal of Cancer (1 paper)Cell Research (1 paper)Molecular Pharmacology (1 paper)The Journal of Steroid Biochemistry and Molecular Biology (1 paper)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Yi He Ling
15 papers receiving 837 citations
Peers
Comparison fields: 5 of 85
- Oncology 303
- Hematology 82
- Molecular Biology 520
- Toxicology 22
- Cancer Research 90
Countries citing papers authored by Yi He Ling
This map shows the geographic impact of Yi He Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi He Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi He Ling more than expected).
Fields of papers citing papers by Yi He Ling
This network shows the impact of papers produced by Yi He Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi He Ling. The network helps show where Yi He Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi He Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. | 2003 | 227 |
| 2 | 1996 | 192 | |
| 3 | PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis. | 2002 | 162 |
| 4 | Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice. | 2000 | 63 |
| 5 | Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties. | 1994 | 45 |
| 6 | Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. | 1998 | 39 |
| 7 | 2009 | 32 | |
| 8 | 2007 | 27 | |
| 9 | Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. | 2000 | 18 |
| 10 | Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells. | 1993 | 17 |
| 11 | 1994 | 12 | |
| 12 | 2008 | 12 | |
| 13 | 2004 | 11 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 1 |
About Yi He Ling
Yi He Ling is a scholar working on Molecular Biology, Oncology, Genetics, Biotechnology and Pharmacology, having authored 15 papers that have together received 859 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Cancer therapeutics and mechanisms (3 papers), Estrogen and related hormone effects (2 papers), Ubiquitin and proteasome pathways (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Research and Treatments (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Oncology (303 citations), Hematology (82 citations), Molecular Biology (520 citations), Toxicology (22 citations) and Cancer Research (90 citations). Yi He Ling has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Román Pérez-Soler, Waldemar Priebe, Adel K. El‐Naggar, Leonard Liebes, Jian Jiang, Julian Adams, Franco M. Muggia, Peter J. Elliott, James F. Holland and Yiyu Zou. Their work appears in journals such as International Journal of Oncology, European Journal of Cancer, Cell Research, Molecular Pharmacology and The Journal of Steroid Biochemistry and Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.